American International Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-30,629
| Closed | -$1.29M | – | 548 |
|
|
2024
Q1 | $1.29M | Buy |
30,629
+7,535
| +33% | +$309K | ﹤0.01% | 1180 |
|
|
2023
Q4 | $916K | Sell |
23,094
-93
| -0.4% | -$2.73K | ﹤0.01% | 1343 |
|
|
2023
Q3 | $638K | Buy |
23,187
+824
| +4% | +$25.8K | ﹤0.01% | 1463 |
|
|
2023
Q2 | $759K | Buy |
22,363
+245
| +1% | +$8.26K | ﹤0.01% | 1396 |
|
|
2023
Q1 | $796K | Buy |
22,118
+441
| +2% | +$19K | 0.01% | 1336 |
|
|
2022
Q4 | $966K | Sell |
21,677
-79
| -0.4% | -$2.82K | 0.01% | 1229 |
|
|
2022
Q3 | $612K | Buy |
21,756
+307
| +1% | +$9.41K | ﹤0.01% | 1452 |
|
|
2022
Q2 | $578K | Sell |
21,449
-1,382
| -6% | -$40.1K | ﹤0.01% | 1513 |
|
|
2022
Q1 | $778K | Sell |
22,831
-1,607
| -7% | -$51.4K | ﹤0.01% | 1484 |
|
|
2021
Q4 | $944K | Sell |
24,438
-731
| -3% | -$31.9K | ﹤0.01% | 1467 |
|
|
2021
Q3 | $1.36M | Buy |
25,169
+3,199
| +15% | +$150K | 0.01% | 1257 |
|
|
2021
Q2 | $735 | Buy |
+21,970
| New | +$603K | ﹤0.01% | 1690 |
|
|
2018
Q2 | – | Sell |
-5,606
| Closed | -$196K | – | 3086 |
|
|
2018
Q1 | $196K | Sell |
5,606
-302
| -5% | -$11.7K | ﹤0.01% | 2270 |
|
|
2017
Q4 | $252K | Buy |
5,908
+499
| +9% | +$21.4K | ﹤0.01% | 2185 |
|
|
2017
Q3 | $232K | Buy |
5,409
+404
| +8% | +$15.1K | ﹤0.01% | 2212 |
|
|
2017
Q2 | $185K | Buy |
5,005
+1,082
| +28% | +$47.9K | ﹤0.01% | 2317 |
|
|
2017
Q1 | $212K | Buy |
3,923
+259
| +7% | +$13.5K | ﹤0.01% | 2147 |
|
|
2016
Q4 | $195K | Sell |
3,664
-9
| -0.2% | -$512 | ﹤0.01% | 2188 |
|
|
2016
Q3 | $223K | Buy |
3,673
+5
| +0.1% | +$311 | ﹤0.01% | 2096 |
|
|
2016
Q2 | $242K | Sell |
3,668
-407
| -10% | -$25.8K | ﹤0.01% | 2010 |
|
|
2016
Q1 | $231K | Sell |
4,075
-13
| -0.3% | -$1.46K | ﹤0.01% | 2642 |
|
|
2015
Q4 | $961K | Buy |
4,088
+82
| +2% | +$17.9K | ﹤0.01% | 1538 |
|
|
2015
Q3 | $634K | Sell |
4,006
-12
| -0.3% | -$3.4K | ﹤0.01% | 1808 |
|
|
2015
Q2 | $1.52M | Buy |
4,018
+93
| +2% | +$36.9K | 0.01% | 1293 |
|
|
2015
Q1 | $1.64M | Buy |
3,925
+55
| +1% | +$19.7K | 0.01% | 1280 |
|
|
2014
Q4 | $1.06M | Sell |
3,870
-155
| -4% | -$38.5K | ﹤0.01% | 1529 |
|
|
2014
Q3 | $782K | Buy |
4,025
+37
| +0.9% | +$8.06K | ﹤0.01% | 1753 |
|
|
2014
Q2 | $976K | Sell |
3,988
-100
| -2% | -$22.6K | ﹤0.01% | 1605 |
|
|
2014
Q1 | $1.08M | Buy |
4,088
+98
| +2% | +$37.5K | 0.01% | 1466 |
|
|
2013
Q4 | $1.45M | Buy |
3,990
+255
| +7% | +$98.2K | 0.01% | 1231 |
|
|
2013
Q3 | $1.99M | Buy |
3,735
+34
| +0.9% | +$11.7K | 0.01% | 1047 |
|
|
2013
Q2 | $867K | Buy |
+3,701
| New | +$729K | 0.01% | 1465 |
|
Other funds holding CLDX
KCM
EAM
PCH
BG
